Taken together, these results suggest that effect on plasmablasts and memory B cells in combination with no increase in activated CD38+ T cells and decrease of Th17 cells could be important parts of the mode of action of MTX in RA. This evidence concerns the gene CD38 and rheumatoid arthritis.